Anekonda T - Search Results

1

Gender effects on plasma and brain copper.

Quinn JF, Harris C, Kaye JA, Lind B, Carter R, Anekonda T, Ralle M. Quinn JF, et al. Among authors: anekonda t. Int J Alzheimers Dis. 2011;2011:150916. doi: 10.4061/2011/150916. Epub 2011 Oct 19. Int J Alzheimers Dis. 2011. PMID: 22028982 Free PMC article.

2

Phytic acid as a potential treatment for alzheimer's pathology: evidence from animal and in vitro models.

Anekonda TS, Wadsworth TL, Sabin R, Frahler K, Harris C, Petriko B, Ralle M, Woltjer R, Quinn JF. Anekonda TS, et al. J Alzheimers Dis. 2011;23(1):21-35. doi: 10.3233/JAD-2010-101287. J Alzheimers Dis. 2011. PMID: 20930278 Free PMC article.

3

L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease.

Anekonda TS, Quinn JF, Harris C, Frahler K, Wadsworth TL, Woltjer RL. Anekonda TS, et al. Neurobiol Dis. 2011 Jan;41(1):62-70. doi: 10.1016/j.nbd.2010.08.020. Epub 2010 Sep 9. Neurobiol Dis. 2011. PMID: 20816785 Free PMC article.

4

Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine.

Anekonda TS, Quinn JF. Anekonda TS, et al. Biochim Biophys Acta. 2011 Dec;1812(12):1584-90. doi: 10.1016/j.bbadis.2011.08.013. Epub 2011 Sep 8. Biochim Biophys Acta. 2011. PMID: 21925266 Free PMC article. Review.

5

A translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drug.

Copenhaver PF, Anekonda TS, Musashe D, Robinson KM, Ramaker JM, Swanson TL, Wadsworth TL, Kretzschmar D, Woltjer RL, Quinn JF. Copenhaver PF, et al. Among authors: anekonda ts. Dis Model Mech. 2011 Sep;4(5):634-48. doi: 10.1242/dmm.006841. Epub 2011 May 19. Dis Model Mech. 2011. PMID: 21596710 Free PMC article.

6

Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.

Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH. Manczak M, et al. Among authors: anekonda ts. Hum Mol Genet. 2006 May 1;15(9):1437-49. doi: 10.1093/hmg/ddl066. Epub 2006 Mar 21. Hum Mol Genet. 2006. PMID: 16551656

7

Neuronal protection by sirtuins in Alzheimer's disease.

Anekonda TS, Reddy PH. Anekonda TS, et al. J Neurochem. 2006 Jan;96(2):305-13. doi: 10.1111/j.1471-4159.2005.03492.x. Epub 2005 Oct 7. J Neurochem. 2006. PMID: 16219030 Free article. Review.

8

Can herbs provide a new generation of drugs for treating Alzheimer's disease?

Anekonda TS, Reddy PH. Anekonda TS, et al. Brain Res Brain Res Rev. 2005 Dec 15;50(2):361-76. doi: 10.1016/j.brainresrev.2005.09.001. Epub 2005 Nov 2. Brain Res Brain Res Rev. 2005. PMID: 16263176 Review.

9

Resveratrol--a boon for treating Alzheimer's disease?

Anekonda TS. Anekonda TS. Brain Res Rev. 2006 Sep;52(2):316-26. doi: 10.1016/j.brainresrev.2006.04.004. Brain Res Rev. 2006. PMID: 16766037 Review.

10

The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy.

Magrys A, Anekonda T, Ren G, Adamus G. Magrys A, et al. Among authors: anekonda t. J Clin Immunol. 2007 Mar;27(2):181-92. doi: 10.1007/s10875-006-9065-8. Epub 2007 Jan 19. J Clin Immunol. 2007. PMID: 17235687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters